---
title: Latest News
description: Company news for investors and health professionals
---
[](https://hemostemix.com)
- [Patient Information](https://hemostemix.com/investigational-treatment-options)
- [Physician Information](https://hemostemix.com/physicians)
- ACP-01
Show submenu for ACP-01
- [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy)
- [Clinical Research](https://hemostemix.com/clinical-research)
- Conditions
Show submenu for Conditions
- [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina)
- [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia)
- [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia)
- [Vascular Dementia](https://hemostemix.com/vascular-dementia)
- [Wound Care](https://hemostemix.com/wound-care)
- Blog
Show submenu for Blog
- [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog)
- [Hemostemix Video Library](https://hemostemix.com/videolibrary)
- [About](https://hemostemix.com/about)
- [Patient Information](https://hemostemix.com/investigational-treatment-options)
- [Physician Information](https://hemostemix.com/physicians)
- ACP-01
Show submenu for ACP-01
- [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy)
- [Clinical Research](https://hemostemix.com/clinical-research)
- Conditions
Show submenu for Conditions
- [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina)
- [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia)
- [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia)
- [Vascular Dementia](https://hemostemix.com/vascular-dementia)
- [Wound Care](https://hemostemix.com/wound-care)
- Blog
Show submenu for Blog
- [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog)
- [Hemostemix Video Library](https://hemostemix.com/videolibrary)
- [About](https://hemostemix.com/about)
[Investor Site](https://investors.hemostemix.com/)
# Latest News
Get the latest news delivered to your inbox.
[**Subscribe Here**](https://hemostemix.com/news-and-events-registration)
All Post
- [All Post](https://hemostemix.com/latest-news)
- [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
- [Latest News](https://hemostemix.com/latest-news/tag/latest-news)
- [Chronic Limb Threatening Ischemia](https://hemostemix.com/latest-news/tag/chronic-limb-threatening-ischemia)
- [Uncategorized](https://hemostemix.com/latest-news/tag/uncategorized)
- [Angina](https://hemostemix.com/latest-news/tag/angina)
- [Stem Cells](https://hemostemix.com/latest-news/tag/stem-cells)
- [Vascular Dementia](https://hemostemix.com/latest-news/tag/vascular-dementia)
- Wound Care
Search
###### [Hemostemix to Attend Centurion One Capital’s Bahamas Summit](https://hemostemix.com/latest-news/hemostemix-to-attend-centurion-one-capitals-bahamas-summit)
[Read More](https://hemostemix.com/latest-news/hemostemix-to-attend-centurion-one-capitals-bahamas-summit)
###### [Hemostemix Non-Brokered Private Placement](https://hemostemix.com/latest-news/hemostemix-non-brokered-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-non-brokered-private-placement)
###### [Dr. Ernst von Schwarz named PI of Hemostemix Longevity Clinical Trial](https://hemostemix.com/latest-news/dr.-ernst-von-schwarz-named-pi-of-hemostemix-longevity-clinical-trial)
[Read More](https://hemostemix.com/latest-news/dr.-ernst-von-schwarz-named-pi-of-hemostemix-longevity-clinical-trial)
###### [Hemostemix’ Longevity Phase I Clinical Trial Leveraging VesCell™’s Excellent Results](https://hemostemix.com/latest-news/hemostemix-longevity-phase-i-clinical-trial-leveraging-vescells-excellent-results)
[Read More](https://hemostemix.com/latest-news/hemostemix-longevity-phase-i-clinical-trial-leveraging-vescells-excellent-results)
###### [Hemostemix grants 6,280,000 options](https://hemostemix.com/latest-news/hemostemix-grants-6280000-options)
[Read More](https://hemostemix.com/latest-news/hemostemix-grants-6280000-options)
###### [Hemostemix CLOSES $360,000 first tranche of PRIVATE PLACEMENT](https://hemostemix.com/latest-news/hemostemix-closes-360000-first-tranche-of-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-360000-first-tranche-of-private-placement)
###### [Hemostemix’ $1,000,000 Private Placement and Update](https://hemostemix.com/latest-news/hemostemix-1000000-private-placement-and-update)
[Read More](https://hemostemix.com/latest-news/hemostemix-1000000-private-placement-and-update)
###### [Dr. Desirée Cox Appointed to Hemostemix’ Board of Directors](https://hemostemix.com/latest-news/dr.-desirée-cox-appointed-to-hemostemix-board-of-directors)
[Read More](https://hemostemix.com/latest-news/dr.-desirée-cox-appointed-to-hemostemix-board-of-directors)
###### [Hemostemix $1,000,000 Private Placement](https://hemostemix.com/latest-news/hemostemix-1000000-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-1000000-private-placement)
###### [Dr. Ernst von Schwarz to Host Webinar: VesCell for Advanced Cardiac Conditions](https://hemostemix.com/latest-news/dr.-ernst-von-schwarz-to-host-webinar-vescell-for-advanced-cardiac-conditions)
[Read More](https://hemostemix.com/latest-news/dr.-ernst-von-schwarz-to-host-webinar-vescell-for-advanced-cardiac-conditions)
###### [HEMOSTEMIX CLOSES $303,967 PRIVATE PLACEMENT AT $0.12 PER SHARE](https://hemostemix.com/latest-news/hemostemix-closes-303967-private-placement-at-0.12-per-share)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-303967-private-placement-at-0.12-per-share)
###### [Hemostemix’s Insider Lead Order of $330,000 Private Placement](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement-1)
[Read More](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement-1)
###### [Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr.York Hsiang, to Advance First Nations–Led Healthcare Partnerships](https://hemostemix.com/latest-news/hemostemix-appoints-renowned-vascular-surgeon-and-principal-investigator-dr.york-hsiang-to-advance-first-nations-led-healthcare-partnerships)
[Read More](https://hemostemix.com/latest-news/hemostemix-appoints-renowned-vascular-surgeon-and-principal-investigator-dr.york-hsiang-to-advance-first-nations-led-healthcare-partnerships)
###### [HEMOSTEMIX RECEIVES FDA SUPPORT FOR ITS BASKET PROTOCOL APPROACH](https://hemostemix.com/latest-news/hemostemix-receives-fda-support-for-its-basket-protocol-approach)
[Read More](https://hemostemix.com/latest-news/hemostemix-receives-fda-support-for-its-basket-protocol-approach)
###### [HEMOSTEMIX CLOSES $480,000 PRIVATE PLACEMENT AT $0.12 PER SHARE](https://hemostemix.com/latest-news/hemostemix-closes-480000-private-placement-at-0.12-per-share)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-480000-private-placement-at-0.12-per-share)
###### [Hemostemix Launches Enhanced HubSpot-Powered Websites to Support Global Marketing & Sales of ACP-01 for No-Option Patients](https://hemostemix.com/latest-news/hemostemix-launches-enhanced-hubspot-powered-websites-to-support-global-marketing-sales-of-acp-01-for-no-option-patients)
[Read More](https://hemostemix.com/latest-news/hemostemix-launches-enhanced-hubspot-powered-websites-to-support-global-marketing-sales-of-acp-01-for-no-option-patients)
###### [Hemostemix Granted Trademark 'KNOW YOUR HEALTH' in Japan.](https://hemostemix.com/latest-news/hemostemix-granted-trademark-know-your-health-in-japan)
[Read More](https://hemostemix.com/latest-news/hemostemix-granted-trademark-know-your-health-in-japan)
###### [Hemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI](https://hemostemix.com/latest-news/hemostemix-announces-its-webinar-for-florida-vascular-surgeons-autologous-stem-cell-therapy-for-clti-1)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-its-webinar-for-florida-vascular-surgeons-autologous-stem-cell-therapy-for-clti-1)
###### [Hemostemix to Showcase Breakthrough Wound Healing Therapy at Innovations in Wound Care Conference Florida](https://hemostemix.com/latest-news/hemostemix-to-showcase-breakthrough-wound-healing-therapy-at-innovations-in-wound-care-conference-florida)
[Read More](https://hemostemix.com/latest-news/hemostemix-to-showcase-breakthrough-wound-healing-therapy-at-innovations-in-wound-care-conference-florida)
###### [Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia](https://hemostemix.com/latest-news/dr.-william-r.-shankle-to-advance-acp-01-as-a-treatment-for-vascular-dementia)
[Read More](https://hemostemix.com/latest-news/dr.-william-r.-shankle-to-advance-acp-01-as-a-treatment-for-vascular-dementia)
###### [Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14](https://hemostemix.com/latest-news/hemostemix-featured-at-innovations-in-wound-healing-2025-key-west-december-11-14)
[Read More](https://hemostemix.com/latest-news/hemostemix-featured-at-innovations-in-wound-healing-2025-key-west-december-11-14)
###### [Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000](https://hemostemix.com/latest-news/hemostemix-inc.-announces-fda-pre-ind-meeting-and-nbpp-of-960000)
[Read More](https://hemostemix.com/latest-news/hemostemix-inc.-announces-fda-pre-ind-meeting-and-nbpp-of-960000)
###### [Hemostemix Grants Stock Options](https://hemostemix.com/latest-news/hemostemix-grants-stock-options)
[Read More](https://hemostemix.com/latest-news/hemostemix-grants-stock-options)
###### [Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations](https://hemostemix.com/latest-news/hemostemix-welcomes-shaune-harding-ostj-rn-as-director-of-patient-care-clinical-operations)
[Read More](https://hemostemix.com/latest-news/hemostemix-welcomes-shaune-harding-ostj-rn-as-director-of-patient-care-clinical-operations)
###### [Hemostemix to Attend DFU 2025 San Antonio and Closed its Private Placement](https://hemostemix.com/latest-news/hemostemix-to-participate-in-dfcon-2025-and-announces-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-to-participate-in-dfcon-2025-and-announces-private-placement)
###### [Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring Two](https://hemostemix.com/latest-news/hemostemix-starts-its-roll-up-of-cardiology-practices-acquiring-two)
[Read More](https://hemostemix.com/latest-news/hemostemix-starts-its-roll-up-of-cardiology-practices-acquiring-two)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Closes CDN $280,594 Private Placement](https://hemostemix.com/latest-news/hemostemix-closes-cdn280594-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-cdn280594-private-placement)
###### [Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds](https://hemostemix.com/latest-news/hemostemix-presents-acp-01-data-at-university-of-florida-grand-rounds)
[Read More](https://hemostemix.com/latest-news/hemostemix-presents-acp-01-data-at-university-of-florida-grand-rounds)
###### [Hemostemix Closes Private Placement of $461,230](https://hemostemix.com/latest-news/hemostemix-closes-private-placement-of-461230)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-private-placement-of-461230)
###### [Hemostemix Announces its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI](https://hemostemix.com/latest-news/hemostemix-announces-its-webinar-for-florida-vascular-surgeons-autologous-stem-cell-therapy-for-clti)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-its-webinar-for-florida-vascular-surgeons-autologous-stem-cell-therapy-for-clti)
###### [Hemostemix Boots on the Ground in Florida - October Update](https://hemostemix.com/latest-news/hemostemix-boots-on-the-ground-in-florida-october-update)
[Read More](https://hemostemix.com/latest-news/hemostemix-boots-on-the-ground-in-florida-october-update)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations), [Latest News](https://hemostemix.com/latest-news/tag/latest-news), [Angina](https://hemostemix.com/latest-news/tag/angina)
###### [Hemostemix Adds the treatment of Refractory Angina to its Phase 1 Basket Protocol](https://hemostemix.com/latest-news/hemostemix-adds-the-treatment-of-refractory-angina-to-its-phase-1-basket-protocol)
[Read More](https://hemostemix.com/latest-news/hemostemix-adds-the-treatment-of-refractory-angina-to-its-phase-1-basket-protocol)
###### [Hemostemix Files for Ethics Approval of its Study of Vascular Dementia](https://hemostemix.com/latest-news/hemostemix-files-for-ethics-approval-of-its-study-of-vascular-dementia)
[Read More](https://hemostemix.com/latest-news/hemostemix-files-for-ethics-approval-of-its-study-of-vascular-dementia)
###### [Hemostemix’s Insider Lead Order of $330,000 Private Placement](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement)
###### [Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell™) Across Multiple Ischemic and Vascular Indications Simultaneously](https://hemostemix.com/latest-news/hemostemix-files-fda-submission-for-basket-protocol-filing-1517-to-advance-acp-01-vescell-across-multiple-ischemic-and-vascular-indications-simultaneously)
[Read More](https://hemostemix.com/latest-news/hemostemix-files-fda-submission-for-basket-protocol-filing-1517-to-advance-acp-01-vescell-across-multiple-ischemic-and-vascular-indications-simultaneously)
###### [Hemostemix to Present its Clinical Data of the Treatment of Severe Angina](https://hemostemix.com/latest-news/hemostemix-to-present-its-clinical-data-of-the-treatment-of-severe-angina)
[Read More](https://hemostemix.com/latest-news/hemostemix-to-present-its-clinical-data-of-the-treatment-of-severe-angina)
###### [Hemostemix to Present at Life Science Investor Forum](https://hemostemix.com/latest-news/hemostemix-to-present-at-life-science-investor-forum)
[Read More](https://hemostemix.com/latest-news/hemostemix-to-present-at-life-science-investor-forum)
###### [Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share](https://hemostemix.com/latest-news/hemostemix-announces-tsxv-approval-of-debt-settlement-at-0.20-per-share)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-tsxv-approval-of-debt-settlement-at-0.20-per-share)
###### [Hemostemix Announces Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-private-placement-1)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-private-placement-1)
###### [Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company)
[Read More](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company)
###### [Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office](https://hemostemix.com/latest-news/hemostemix-your-fountain-of-youth-trademark-granted-by-japan-patent-office)
[Read More](https://hemostemix.com/latest-news/hemostemix-your-fountain-of-youth-trademark-granted-by-japan-patent-office)
###### [Hemostemix Announces Engagement of Oak Hill Asset Management Inc.](https://hemostemix.com/latest-news/hemostemix-announces-engagement-of-oak-hill-asset-management-inc)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-engagement-of-oak-hill-asset-management-inc)
###### [Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial](https://hemostemix.com/latest-news/hemostemixs-pitch-to-wall-street-acp-01-vascular-dementia-trial-will-generate-5365000-capture-data-as-a-phase-1-clinical-trial)
[Read More](https://hemostemix.com/latest-news/hemostemixs-pitch-to-wall-street-acp-01-vascular-dementia-trial-will-generate-5365000-capture-data-as-a-phase-1-clinical-trial)
###### [Hemostemix Unit Offering Repriced](https://hemostemix.com/latest-news/hemostemix-unit-offering-repriced)
[Read More](https://hemostemix.com/latest-news/hemostemix-unit-offering-repriced)
###### [Hemostemix Announces Unit Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement)
###### [Hemostemix Closes $403,539 of the Unit Private Placement](https://hemostemix.com/latest-news/hemostemix-closes-403539-of-the-unit-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-403539-of-the-unit-private-placement)
###### [Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company-2)
[Read More](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company-2)
###### [Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund up to 75% of 5-Year Costs](https://hemostemix.com/latest-news/hemostemix-hiring-4-new-biotechnologists-in-montreal-and-appling-for-grants-to-fund-up-to-75-of-5-year-costs)
[Read More](https://hemostemix.com/latest-news/hemostemix-hiring-4-new-biotechnologists-in-montreal-and-appling-for-grants-to-fund-up-to-75-of-5-year-costs)
###### [Hemostemix Announces its AI Strategy](https://hemostemix.com/latest-news/hemostemix-announces-its-ai-strategy)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-its-ai-strategy)
###### [Hemostemix’s Private Placement Use of Proceeds](https://hemostemix.com/latest-news/hemostemixs-private-placement-use-of-proceeds)
[Read More](https://hemostemix.com/latest-news/hemostemixs-private-placement-use-of-proceeds)
###### [Hemostemix Announces Advancements in its Automation of Production](https://hemostemix.com/latest-news/hemostemix-announces-advancements-in-its-automation-of-production)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-advancements-in-its-automation-of-production)
###### [Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors](https://hemostemix.com/latest-news/hemostemix-contracts-proconsul-to-ramp-up-engagement-with-new-investors-2)
[Read More](https://hemostemix.com/latest-news/hemostemix-contracts-proconsul-to-ramp-up-engagement-with-new-investors-2)
###### [Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share](https://hemostemix.com/latest-news/hemostemix-closes-private-placement-of-usd-336500-at-0-295-per-share)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-private-placement-of-usd-336500-at-0-295-per-share)
###### [Hemostemix’s Private Placement](https://hemostemix.com/latest-news/hemostemixs-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemixs-private-placement)
###### [Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences](https://hemostemix.com/latest-news/hemostemix-announces-updated-phase-ii-randomized-clinical-trial-results-published-by-the-journal-of-biomedical-research-and-environmental-sciences)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-updated-phase-ii-randomized-clinical-trial-results-published-by-the-journal-of-biomedical-research-and-environmental-sciences)
###### [Hemostemix Announces Trademark Granted by Switzerland and Interest Payment](https://hemostemix.com/latest-news/hemostemix-announces-trademark-granted-by-switzerland-and-interest-payment)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-trademark-granted-by-switzerland-and-interest-payment)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Settlement via Depository Trust Company Plus OTCQB Update](https://hemostemix.com/latest-news/hemostemix-settlement-via-depository-trust-company-plus-otcqb-update)
[Read More](https://hemostemix.com/latest-news/hemostemix-settlement-via-depository-trust-company-plus-otcqb-update)
###### [Hemostemix Oversubscribed, Closing $2,700,000 Private Placement and Settles $400,000 of Debt at $0.20 per Share](https://hemostemix.com/latest-news/hemostemix-oversubscribed-closing-2700000-private-placement-and-settles-400000-of-debt-at-0-20-per-share)
[Read More](https://hemostemix.com/latest-news/hemostemix-oversubscribed-closing-2700000-private-placement-and-settles-400000-of-debt-at-0-20-per-share)
###### [Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market](https://hemostemix.com/latest-news/hemostemix-announces-ncp-01-study-to-address-a-10-billion-pain-market)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-ncp-01-study-to-address-a-10-billion-pain-market)
###### [Hemostemix Closes $2,969,600 Private Placement](https://hemostemix.com/latest-news/hemostemix-closes-2969600-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-2969600-private-placement)
###### [Hemostemix Presents at TERMIS 2025, Freiburg, Germany](https://hemostemix.com/latest-news/hemostemix-presents-at-termis-2025-freiburg-germany)
[Read More](https://hemostemix.com/latest-news/hemostemix-presents-at-termis-2025-freiburg-germany)
###### [Hemostemix Announces Exploring Clinical Trial Financing Alternatives](https://hemostemix.com/latest-news/hemostemix-announces-exploring-clinical-trial-financing-alternatives)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-exploring-clinical-trial-financing-alternatives)
###### [Hemostemix’s Social Media for Investors and Florida’s No-Option Patients](https://hemostemix.com/latest-news/hemostemixs-social-media-for-investors-and-floridas-no-option-patients)
[Read More](https://hemostemix.com/latest-news/hemostemixs-social-media-for-investors-and-floridas-no-option-patients)
###### [Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-nadia-giannetti-md-to-its-scientific-advisory-board)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-nadia-giannetti-md-to-its-scientific-advisory-board)
###### [Hemostemix’s Expands its Marketing Team Focused on Sales in Florida](https://hemostemix.com/latest-news/hemostemixs-expands-its-marketing-team-focused-on-sales-in-florida)
[Read More](https://hemostemix.com/latest-news/hemostemixs-expands-its-marketing-team-focused-on-sales-in-florida)
###### [Hemostemix Closed $320,125 Private Placement](https://hemostemix.com/latest-news/hemostemix-closed-320125-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closed-320125-private-placement)
###### [Hemostemix Submits its Retrospective Heart Study to Leading Stem Cell Journal and has Prepared its CLI Phase II Clinical Trial Manuscript for Peer Review](https://hemostemix.com/latest-news/hemostemix-submits-its-retrospective-heart-study-to-leading-stem-cell-journal-and-has-prepared-its-cli-phase-ii-clinical-trial-manuscript-for-peer-review)
[Read More](https://hemostemix.com/latest-news/hemostemix-submits-its-retrospective-heart-study-to-leading-stem-cell-journal-and-has-prepared-its-cli-phase-ii-clinical-trial-manuscript-for-peer-review)
###### [Hemostemix’s Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to Biocardia’s Cardiamp Heart Failure Trial](https://hemostemix.com/latest-news/elementor-3891)
[Read More](https://hemostemix.com/latest-news/elementor-3891)
###### [Hemostemix’s VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!](https://hemostemix.com/latest-news/hemostemixs-vescell-sales-are-legal-in-florida-as-it-pivots-to-allow-non-fda-approved-stem-cell-treatments)
[Read More](https://hemostemix.com/latest-news/hemostemixs-vescell-sales-are-legal-in-florida-as-it-pivots-to-allow-non-fda-approved-stem-cell-treatments)
###### [Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01](https://hemostemix.com/latest-news/hemostemix-closes-its-funded-manufacturing-services-agreement-with-cytoimmune-restarting-production-of-acp-01)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-its-funded-manufacturing-services-agreement-with-cytoimmune-restarting-production-of-acp-01)
###### [Hemostemix Announces Closing of Second Tranche of UNIT Private Placement](https://hemostemix.com/latest-news/elementor-3849)
[Read More](https://hemostemix.com/latest-news/elementor-3849)
###### [Hemostemix Announces Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-private-placement)
###### [Cells: Hemostemix ACP-01 and NCP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants](https://hemostemix.com/latest-news/cells-hemostemix-acp-01-and-ncp-01-provides-the-scientific-basis-for-improving-the-longevity-and-signal-uptake-of-brain-computer-implants)
[Read More](https://hemostemix.com/latest-news/cells-hemostemix-acp-01-and-ncp-01-provides-the-scientific-basis-for-improving-the-longevity-and-signal-uptake-of-brain-computer-implants)
###### [Hemostemix Issued “Your Fountain of Youth” Trademark by Cyprus](https://hemostemix.com/latest-news/hemostemix-issued-your-fountain-of-youth-trademark-by-cyprus)
[Read More](https://hemostemix.com/latest-news/hemostemix-issued-your-fountain-of-youth-trademark-by-cyprus)
###### [Hemostemix Offers up to 500 6% Convertible Debentures, Convertible into an ACP-01 Therapeutic Production Slot that is Subject to Compassionate Exemption from Regulatory Approval](https://hemostemix.com/latest-news/hemostemix-offers-up-to-500-6-convertible-debentures-convertible-into-an-acp-01-therapeutic-production-slot-that-is-subject-to-compassionate-exemption-from-regulat)
[Read More](https://hemostemix.com/latest-news/hemostemix-offers-up-to-500-6-convertible-debentures-convertible-into-an-acp-01-therapeutic-production-slot-that-is-subject-to-compassionate-exemption-from-regulat)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Up-lists to TradeGateExchange in Germany](https://hemostemix.com/latest-news/hemostemix-up-lists-to-tradegateexchange-in-germany)
[Read More](https://hemostemix.com/latest-news/hemostemix-up-lists-to-tradegateexchange-in-germany)
###### [Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA™) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01](https://hemostemix.com/latest-news/hemostemix-and-firefly-neurosciences-brain-network-analytics-bna-engage-to-complete-phase-1-vascular-dementia-clinical-trial-of-acp-01)
[Read More](https://hemostemix.com/latest-news/hemostemix-and-firefly-neurosciences-brain-network-analytics-bna-engage-to-complete-phase-1-vascular-dementia-clinical-trial-of-acp-01)
###### [Hemostemix Sells its 23rd ACP-01 Therapy Convertible Debenture](https://hemostemix.com/latest-news/hemostemix-sells-its-23rd-acp-01-therapy-convertible-debenture)
[Read More](https://hemostemix.com/latest-news/hemostemix-sells-its-23rd-acp-01-therapy-convertible-debenture)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-Up](https://hemostemix.com/latest-news/hemostemix-and-cytoimmune-amend-manufacturing-agreement-to-accelerate-global-scale-up)
[Read More](https://hemostemix.com/latest-news/hemostemix-and-cytoimmune-amend-manufacturing-agreement-to-accelerate-global-scale-up)
###### [Hemostemix’ Second Round Interviews with Executive Vice President Business Development Candidates](https://hemostemix.com/latest-news/hemostemix-second-round-interviews-with-executive-vice-president-business-development-candidates)
[Read More](https://hemostemix.com/latest-news/hemostemix-second-round-interviews-with-executive-vice-president-business-development-candidates)
###### [Hemostemix Contracts Empire Market Ventures to Increase Market Awareness](https://hemostemix.com/latest-news/hemostemix-contracts-empire-market-ventures-to-increase-market-awareness)
[Read More](https://hemostemix.com/latest-news/hemostemix-contracts-empire-market-ventures-to-increase-market-awareness)
###### [Hemostemix Clarifies its October 3, 2023 News Release](https://hemostemix.com/latest-news/hemostemix-clarifies-its-october-3-2023-news-release)
[Read More](https://hemostemix.com/latest-news/hemostemix-clarifies-its-october-3-2023-news-release)
###### [Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to its Scientific Advisory Board](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-renzo-cecere-md-frcsc-to-its-scientific-advisory-board)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-renzo-cecere-md-frcsc-to-its-scientific-advisory-board)
###### [Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000](https://hemostemix.com/latest-news/hemostemix-announces-amendment-of-its-2-5-million-5-year-convertible-debenture-issued-on-june-11-2021-resulting-in-an-expected-interest-saving-of-approximately-570)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-amendment-of-its-2-5-million-5-year-convertible-debenture-issued-on-june-11-2021-resulting-in-an-expected-interest-saving-of-approximately-570)
###### [Hemostemix Closing $3,000,000 Private Placement and Issues TCDs](https://hemostemix.com/latest-news/hemostemix-closing-3000000-private-placement-and-issues-tcds)
[Read More](https://hemostemix.com/latest-news/hemostemix-closing-3000000-private-placement-and-issues-tcds)
###### [Hemostemix Announces A Clarification](https://hemostemix.com/latest-news/hemostemix-announces-a-clarification)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-a-clarification)
###### [HEMOSTEMIX CLOSES $762,400 OF THE UNIT PRIVATE PLACEMENT](https://hemostemix.com/latest-news/hemostemix-closes-762400-of-the-unit-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-762400-of-the-unit-private-placement)
###### [Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch](https://hemostemix.com/latest-news/croom-lawrence-joins-hemostemix-with-revenue-share-agreement-and-vescell-health-launch)
[Read More](https://hemostemix.com/latest-news/croom-lawrence-joins-hemostemix-with-revenue-share-agreement-and-vescell-health-launch)
###### [Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board](https://hemostemix.com/latest-news/hemostemix-licenses-cytoimmunes-bioreactor-technologies)
[Read More](https://hemostemix.com/latest-news/hemostemix-licenses-cytoimmunes-bioreactor-technologies)
###### [Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to its Scientific Advisory Board](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-terry-hebert-phd-to-its-scientific-advisory-board)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-appointment-of-dr-terry-hebert-phd-to-its-scientific-advisory-board)
###### [Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments](https://hemostemix.com/latest-news/hemostemix-announces-strategic-manufacturing-partnership-with-cytoimmune-therapeutics-and-1800000-in-financing-commitments)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-strategic-manufacturing-partnership-with-cytoimmune-therapeutics-and-1800000-in-financing-commitments)
###### [HEMOSTEMIX ANNOUNCES $2,725,982, UPDATE TO SECOND CLOSING](https://hemostemix.com/latest-news/hemostemix-announces-2725982-update-to-second-closing)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-2725982-update-to-second-closing)
###### [Hemostemix Announces its Presentation to the Emerging Growth Conference](https://hemostemix.com/latest-news/hemostemix-announces-its-presentation-to-the-emerging-growth-conference)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-its-presentation-to-the-emerging-growth-conference)
###### [HEMOSTEMIX CLOSES SALE OF 23RD ACP-01 THERAPY CONVERTIBLE DEBENTURE](https://hemostemix.com/latest-news/hemostemix-closes-sale-of-23rd-acp-01-therapy-convertible-debenture)
[Read More](https://hemostemix.com/latest-news/hemostemix-closes-sale-of-23rd-acp-01-therapy-convertible-debenture)
###### [Hemostemix Announces Presentation to the Emerging Growth Conference](https://hemostemix.com/latest-news/hemostemix-announces-presentation-to-the-emerging-growth-conference)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-presentation-to-the-emerging-growth-conference)
###### [Hemostemix Wins Arbitration Decision](https://hemostemix.com/latest-news/hemostemix-wins-arbitration-decision)
[Read More](https://hemostemix.com/latest-news/hemostemix-wins-arbitration-decision)
###### [HEMOSTEMIX ANNOUNCES THE FIRST TRANCHE CLOSING OF $1.8M OF ITS RECENTLY ANNOUNCED PRIVATE PLACEMENT](https://hemostemix.com/latest-news/elementor-3580)
[Read More](https://hemostemix.com/latest-news/elementor-3580)
###### [Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-quebec-inc-and-6-million-in-grant-applications)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-quebec-inc-and-6-million-in-grant-applications)
###### [Hemostemix Closes $469,366 Private Placement](https://hemostemix.com/latest-news/elementor-3879)
[Read More](https://hemostemix.com/latest-news/elementor-3879)
###### [Hemostemix Increases Previously Closed Private Placement to $3,000,000](https://hemostemix.com/latest-news/hemostemix-increases-previously-closed-private-placement-to-3000000)
[Read More](https://hemostemix.com/latest-news/hemostemix-increases-previously-closed-private-placement-to-3000000)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix is up-listing in the USA to generate liquidity](https://hemostemix.com/latest-news/hemostemix-is-up-listing-in-the-usa-to-generate-liquidity)
[Read More](https://hemostemix.com/latest-news/hemostemix-is-up-listing-in-the-usa-to-generate-liquidity)
###### [HEMOSTEMIX’S SOCIAL MEDIA AWARENESS OF “YOUR FOUNTAIN OF YOUTH” (TM) REGENERATIVE MEDICINE TREATMENTS IS GAINING TRACTION](https://hemostemix.com/latest-news/hemostemixs-social-media-awareness-of-your-fountain-of-youth-tm-regenerative-medicine-treatments-is-gaining-traction)
[Read More](https://hemostemix.com/latest-news/hemostemixs-social-media-awareness-of-your-fountain-of-youth-tm-regenerative-medicine-treatments-is-gaining-traction)
###### [Hemostemix Thanks Niem Malo, Beefstro’s Founder, for his ACP-01 Testimonial Interview](https://hemostemix.com/latest-news/hemostemix-thanks-niem-malo-beefstros-founder-for-his-acp-01-testimonial-interview)
[Read More](https://hemostemix.com/latest-news/hemostemix-thanks-niem-malo-beefstros-founder-for-his-acp-01-testimonial-interview)
###### [Hemostemix Announces Letter of Commitment, Non-dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation](https://hemostemix.com/latest-news/hemostemix-announces-letter-of-commitment-non-dilutive-funding-structure-and-250000-of-funding-by-the-mcgill-university-health-centre-foundation)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-letter-of-commitment-non-dilutive-funding-structure-and-250000-of-funding-by-the-mcgill-university-health-centre-foundation)
###### [Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-arbitration-award-of-cad-315684-plus-private-placement)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-arbitration-award-of-cad-315684-plus-private-placement)
###### [Hemostemix PR Inc. Congratulates Luis Muñoz Marín International Airport on Achieving CEIV Pharma Certification](https://hemostemix.com/latest-news/hemostemix-pr-inc-congratulates-luis-munoz-marin-international-airport-on-achieving-ceiv-pharma-certification-2)
[Read More](https://hemostemix.com/latest-news/hemostemix-pr-inc-congratulates-luis-munoz-marin-international-airport-on-achieving-ceiv-pharma-certification-2)
###### [Hemostemix Announces Unit Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement-2)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-unit-private-placement-2)
###### [Hemostemix Licenses CytoImmune’s BioReactor Technologies](https://hemostemix.com/latest-news/hemostemix-licenses-cytoimmunes-bioreactor-technologies-2)
[Read More](https://hemostemix.com/latest-news/hemostemix-licenses-cytoimmunes-bioreactor-technologies-2)
###### [Hemostemix’s 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease](https://hemostemix.com/latest-news/hemostemixs-4th-heart-study-published-in-stem-cell-research-therapy-confirms-breakthrough-treatment-for-heart-disease)
[Read More](https://hemostemix.com/latest-news/hemostemixs-4th-heart-study-published-in-stem-cell-research-therapy-confirms-breakthrough-treatment-for-heart-disease)
###### [Hemostemix’s Boots on the Ground in Florida](https://hemostemix.com/latest-news/hemostemixs-boots-on-the-ground-in-florida)
[Read More](https://hemostemix.com/latest-news/hemostemixs-boots-on-the-ground-in-florida)
###### [Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio](https://hemostemix.com/latest-news/hemostemix-engages-patentvest-to-strengthen-its-global-patent-portfolio)
[Read More](https://hemostemix.com/latest-news/hemostemix-engages-patentvest-to-strengthen-its-global-patent-portfolio)
###### [HEMOSTEMIX ANNOUNCES ACP-01 TREATMENT-PURCHASE AVAILABLE WITH SOCIAL MEDIA CAMPAIGN UNDERWAY](https://hemostemix.com/latest-news/hemostemix-announces-acp-01-treatment-purchase-available-with-social-media-campaign-underway)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-acp-01-treatment-purchase-available-with-social-media-campaign-underway)
###### [Hemostemix Announces the Incorporation of PreCerv Inc. and a Global Field of Use License to NCP-01](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-precerv-inc-and-a-global-field-of-use-license-to-ncp-01)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-precerv-inc-and-a-global-field-of-use-license-to-ncp-01)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% reimbursement of R&D expenses in cash](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-pr-inc-50-reimbursement-of-rd-expenses-in-cash)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-the-incorporation-of-hemostemix-pr-inc-50-reimbursement-of-rd-expenses-in-cash)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic Impact](https://hemostemix.com/latest-news/hemostemix-presents-at-puerto-rico-investor-summits-showcasing-global-scale-up-strategy-and-economic-impact)
[Read More](https://hemostemix.com/latest-news/hemostemix-presents-at-puerto-rico-investor-summits-showcasing-global-scale-up-strategy-and-economic-impact)
[Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations)
###### [Hemostemix Announces First Sales Orders for ACP-01](https://hemostemix.com/latest-news/hemostemix-announces-first-sales-orders-for-acp-01)
[Read More](https://hemostemix.com/latest-news/hemostemix-announces-first-sales-orders-for-acp-01)
[](https://hemostemix.com)
Leave us a message
Follow Us
Copyright © 2026 Hemostemix, Inc
[Privacy Policy |](https://hemostemix.com/privacy-policy) [Terms of Service](https://hemostemix.com/sms-terms-of-service)